Surgery Partners, Inc.

NASDAQ:SGRY

25.505 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 770.4762.1717.4735.4674.1667.6666.2707.1620.6615.4596.2610.2559.2543.3512.4548.3496.1374.7441517.2452445.4416.8491.168443.932444.775417.369460.346282.682288.353286.183306.001282.682289.681267.074263.322239.599232.827224.143179.69176.30375.10869.158
Cost of Revenue 592.9582.9595.8572.9508.3513.5532.2522.8489.4480.8471.4463.1436.7425408.9412.9381.9319.3366.2388353.1340.4326.1359.74334.289340.09327.312338.704201.394216.452211.948214.247201.394208.852196.703183.174168.821161.558155.773120.58745.37745.16143.053
Gross Profit 177.5179.2121.6162.5165.8154.1134184.3131.2134.6124.8147.1122.5118.3103.5135.4114.255.474.8129.298.910590.7131.428109.643104.68590.057121.64281.28871.90174.23591.75481.28880.82970.37180.14870.77871.26968.3759.10430.92629.94726.105
Gross Profit Ratio 0.230.2350.170.2210.2460.2310.2010.2610.2110.2190.2090.2410.2190.2180.2020.2470.230.1480.170.250.2190.2360.2180.2680.2470.2350.2160.2640.2880.2490.2590.30.2880.2790.2630.3040.2950.3060.3050.3290.4050.3990.377
Reseach & Development Expenses 0000000000000000000000000000000000000000000
General & Administrative Expenses 120.240.333.220.9109.231.23228.717.926.129.527.225.524.526.823.825.225.322.823.719.923.321.723.82919.47826.09924.15221.37635.84118.65515.54118.04114.98515.02312.19721.04811.23611.84611.86211.4146.7386.4656.835
Selling & Marketing Expenses 00-82.60000000000000000000000000272.15900000000000000
SG&A 120.240.333.220.9109.231.23228.717.926.129.527.225.524.526.823.825.225.322.823.719.923.321.723.82919.47826.09924.15221.37630818.65515.54118.04114.98515.02312.19721.04811.23611.84611.86211.4146.7386.4656.835
Other Expenses 000-32.601.232.6292.425.326.212.20.517.510.614.234-19.901,352.100-2.41,454.59910.260025.3292.59900807.525-3.73304.24-119.9110000000
Operating Expenses 120.240.333.220.9109.254.464.657.747.251.455.73250.24237.436.359.25.443.142.938.34240.541.72346.77148.84845.67648.65330835.69932.18136.1733.57628.30725.60235.54725.41425.37125.49719.65410.9559.43611.738
Operating Income 60.984.888.4141.682.697.672.4140.274.176.574.6114.863.659.564.396.318.544.723.571.85955.549.6-51.88945.00343.56141.16380.34442.84837.73941.72168.40742.84850.94834.2821.12844.27441.00138.351-3.66719.65420.6216.41
Operating Income Ratio 0.0790.1110.1230.1930.1230.1460.1090.1980.1190.1240.1250.1880.1140.110.1250.1760.0370.1190.0530.1390.1310.1250.119-0.1060.1010.0980.0990.1750.1520.1310.1460.2240.1520.1760.1280.080.1850.1760.171-0.020.2580.2750.237
Total Other Income Expenses Net -50-51.5-47.3-48.7-49.8-47.7-46.8-61-60.7-56.9-56.3-60.1-54.2-53.4-53.3-54-51.5-49.2-47.1-44.8-45.7-46.4-44.4-39.635-37.159-35.933-34.276-7.528-17.638-25.6-25.182-25.708-30.208-26.235-22.153-142.384-26.573-26.178-25.756-29.383-11.263-11.408-10.106
Income Before Tax 10.933.328.752.732.849.9-0.433.213.419.644.154.79.46.11142.3-33-4.5-23.62713.39.15.2-91.5247.8447.6286.88772.81612.6412.13916.53942.69912.6424.71312.127-121.25617.70114.82312.595-33.058.3919.1034.261
Income Before Tax Ratio 0.0140.0440.040.0720.0490.075-0.0010.0470.0220.0320.0740.090.0170.0110.0210.077-0.067-0.012-0.0540.0520.0290.020.012-0.1860.0180.0170.0170.1580.0450.0420.0580.140.0450.0850.045-0.460.0740.0640.056-0.1840.110.1210.062
Income Tax Expense -4.54.94.46-3.1-7.8-1.69.97.84.31.311.81.2-2.70.2-5.61.3-0.6-15.23.42.411.715.5565.8253.3181.76271.85-1.6940.5122.1174.599-1.6942.421.77-157.353.9172.3442.1073.7157.9612.1181.963
Net Income -31.7-15.5-12.4-135.918.91.223.3-2515.342.8-0.1-22.9-26.9-215.5-61.6-32.5-27.5-18.2-15.7-19.8-20.1-147.742-20.981-19.462-17.521-32.17614.334-4.471-2.75416.862-2.3382.12-7.1916.739-3.122-5.426-6.762-54.264-6.908-0.647-4.079
Net Income Ratio -0.041-0.02-0.017-0.0010.0530.0280.0020.033-0.040.0250.072-0-0.041-0.05-0.0410.01-0.124-0.087-0.062-0.035-0.035-0.044-0.048-0.301-0.047-0.044-0.042-0.070.051-0.016-0.010.055-0.0080.007-0.0270.064-0.013-0.023-0.03-0.302-0.091-0.009-0.059
EPS -0.25-0.12-0.098-0.0080.290.150.010.23-0.280.170.49-0.001-0.28-0.39-0.38-0.1-1.26-0.67-0.57-0.38-0.32-0.41-0.42-3.07-0.44-0.41-0.37-0.670.3-0.093-0.060.35-0.050.04-0.150.35-0.065-0.11-0.14-1.13-0.1400
EPS Diluted -0.25-0.12-0.098-0.0080.290.150.010.23-0.280.170.47-0.001-0.28-0.39-0.38-0.1-1.26-0.67-0.57-0.38-0.32-0.41-0.42-3.07-0.44-0.41-0.36-0.670.29-0.093-0.0570.35-0.0490.04-0.150.35-0.065-0.11-0.14-1.13-0.1400
EBITDA -36119.6109.7172.7111.512280.1169.8103.9104.5127.8137.588.884.790121.842.668.145.39277.474.669-34.42861.94860.24656.91298.50231.22149.15652.82978.97448.82860.65143.848-239.67552.88549.46646.8132.83722.80623.48219.27
EBITDA Ratio -0.0470.1570.170.2350.0180.190.1590.240.1910.1850.1710.250.180.1920.1840.2330.1660.2030.1260.2130.180.1890.1650.2250.1840.1690.1490.259-0.0150.1690.190.2220.1940.2190.206-0.2480.2310.2370.2320.2630.2990.3130.279